REGISTERED NUMBER: 10335368 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 August 2025

for

Danamma Medical Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr M D Hulgur

Dr M Y Mothi

REGISTERED OFFICE:

Perrott House

17 Bridge Street

Pershore

Worcestershire

WR10 1AJ

REGISTERED NUMBER:

10335368 (England and Wales)

ACCOUNTANTS:

Attwoods

Perrott House

17 Bridge Street

Pershore

Worcestershire

WR10 1AJ

FIXED ASSETS

Tangible assets

4

23,152

27,578

Investments

5

12,846

4,009

35,998

31,587

CURRENT ASSETS

Debtors

6

568,769

568,769

Cash at bank and in hand

642,405

369,698

1,211,174

938,467

CREDITORS

Amounts falling due within one year

7

137,690

83,280

NET CURRENT ASSETS

1,073,484

855,187

TOTAL ASSETS LESS CURRENT LIABILITIES

1,109,482

886,774

CAPITAL AND RESERVES

Called up share capital

(2,000

)

(2,000

)

Fair value reserve

8

429

-

Retained earnings

1,111,053

888,774

1,109,482

886,774

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2026 and were signed on its behalf by:

Dr M D Hulgur - Director

1.	STATUTORY INFORMATION

Danamma Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

20% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Motor vehicles

-

20% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - NIL ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Motor

Computer

machinery

fittings

vehicles

equipment

Totals

£

£

£

£

£

COST

At 1 September 2024

2,075

13,260

24,650

-

39,985

Additions

-

935

-

1,650

2,585

At 31 August 2025

2,075

14,195

24,650

1,650

42,570

DEPRECIATION

At 1 September 2024

1,713

5,764

4,930

-

12,407

Charge for year

65

1,686

4,930

330

7,011

At 31 August 2025

1,778

7,450

9,860

330

19,418

NET BOOK VALUE

At 31 August 2025

297

6,745

14,790

1,320

23,152

At 31 August 2024

362

7,496

19,720

-

27,578

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 September 2024

4,009

Additions

8,400

Revaluations

429

Dividends received

8

At 31 August 2025

12,846

NET BOOK VALUE

At 31 August 2025

12,846

At 31 August 2024

4,009

Cost or valuation at 31 August 2025 is represented by:

Other

investments

£

Valuation in 2025

437

Cost

12,409

12,846

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.8.25

31.8.24

£

£

Other debtors

568,769

568,769

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.8.25

31.8.24

£

£

Taxation

75,146

43,321

Directors' current accounts

60,443

38,608

Accrued expenses

2,101

1,351

137,690

83,280

8.

RESERVES

Fair

value

reserve

£

Revaluation

429

At 31 August 2025

429